{"id":"levomoprolol","rwe":[{"pmid":"2571957","year":"1989","title":"[The hemodynamic effects on the portal system of levomoprolol and propranolol in rats with an enhanced adrenergic tonus].","finding":"","journal":"Minerva medica","studyType":"Clinical Study"},{"pmid":"2570078","year":"1989","title":"Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration.","finding":"","journal":"Journal of chromatography","studyType":"Clinical Study"},{"pmid":"2878862","year":"1986","title":"[Long-term treatment of wide-angle glaucoma with the beta blocker levomoprolol: therapeutic effectiveness without side effects].","finding":"","journal":"Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft","studyType":"Clinical Study"},{"pmid":"2861871","year":"1985","title":"[The beta-blocker levomoprolol in the treatment of glaucoma].","finding":"","journal":"Bulletins et memoires de la Societe francaise d'ophtalmologie","studyType":"Clinical Study"},{"pmid":"6152549","year":"1984","title":"[Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].","finding":"","journal":"Cardiologia (Rome, Italy)","studyType":"Clinical Study"}],"tags":[{"label":"levomoprolol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"levotensin","offLabel":[],"synonyms":["levomoprolol","(-)-Moprolol","levotensin","l-Moprolol"],"timeline":[],"approvals":[],"brandName":"Levotensin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"levomoprolol","explanation":"Think of adrenergic receptors like locks on a door. Levotensin is a key that fits into these locks, which can help slow down the heart rate and reduce blood pressure. This can be helpful for people with certain heart conditions.","oneSentence":"Levotensin works by interacting with the body's adrenergic receptors.","technicalDetail":"Levotensin is a selective beta-1 adrenergic receptor antagonist, which means it binds to and blocks the action of beta-1 adrenergic receptors in the heart, leading to a decrease in heart rate and contractility."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3981","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LEVOMOPROLOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:06:38.962015","biosimilars":[],"competitors":[],"genericName":"levomoprolol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"K4NON6FSON","CHEBI":"CHEBI:134973","INN_ID":"6150","UMLSCUI":"C0125658","ChEMBL_ID":"CHEMBL2106030","PUBCHEM_CID":"3034006"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":5,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"recentPublications":[{"date":"1989 Aug","pmid":"2571957","title":"[The hemodynamic effects on the portal system of levomoprolol and propranolol in rats with an enhanced adrenergic tonus].","journal":"Minerva medica"},{"date":"1989 Jul 7","pmid":"2570078","title":"Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration.","journal":"Journal of chromatography"},{"date":"1986","pmid":"2878862","title":"[Long-term treatment of wide-angle glaucoma with the beta blocker levomoprolol: therapeutic effectiveness without side effects].","journal":"Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft"},{"date":"1985","pmid":"2861871","title":"[The beta-blocker levomoprolol in the treatment of glaucoma].","journal":"Bulletins et memoires de la Societe francaise d'ophtalmologie"},{"date":"1984 Dec","pmid":"6152549","title":"[Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].","journal":"Cardiologia (Rome, Italy)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levotensin, also known as levomoprolol, is a small molecule drug in the levomoprolol class. Its exact target and mechanism of action are unknown, but it is believed to work by interacting with the body's adrenergic receptors. Levotensin is not FDA-approved for any indications, and its commercial status, including patent status and generic availability, is unclear. Further research is needed to determine its safety and efficacy. As a result, levotensin is not currently available for clinical use.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}